These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20391294)

  • 1. Disorders of hemostasis associated with chronic kidney disease.
    Jalal DI; Chonchol M; Targher G
    Semin Thromb Hemost; 2010 Feb; 36(1):34-40. PubMed ID: 20391294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of hemostasis in chronic renal failure and renal transplantation].
    Goluza E; Topalović MG; Hudolin T; Konosić S; Kocman IB; Perić M
    Acta Med Croatica; 2011; 65(4):337-47. PubMed ID: 22359906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A risk factors for stroke in the patients with chronic kidney disease].
    Kes P; Basić-Kes V; Basić-Jukić N; Jurić I
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():67-77. PubMed ID: 23120820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment anaemia of chronic kidney disease in predialysis patients (stage 1-4)].
    Lovcić V; Vujić J; Ivanac Janković R; Basić-Jukić N; Barisić I; Lovcić P; Dzapo M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():11-6. PubMed ID: 20232547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of modulating the renin-angiotensin system in preventing renal complications of hypertension.
    Rayner B
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):469-80. PubMed ID: 17186680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of coronary artery disease in patients with chronic kidney disease.
    Coats WC; Baig SZ; Alpert MA; Aggarwal K
    Adv Perit Dial; 2009; 25():125-8. PubMed ID: 19886333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in children with chronic kidney disease.
    Shatat IF; Flynn JT
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):378-84. PubMed ID: 16198277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
    Toto R; Palmer BF
    Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the use of vitamin K antagonists harmful in patients with CDK?].
    Pham TT; Saudan P
    Rev Med Suisse; 2012 Feb; 8(330):462-5. PubMed ID: 22452132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
    Chikotas N; Gunderman A; Oman T
    J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA; Onuigbo NT
    Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver.
    Targher G; Zoppini G; Moghetti P; Day CP
    Semin Thromb Hemost; 2010 Feb; 36(1):41-8. PubMed ID: 20391295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical findings in oral health during progression of chronic kidney disease to end-stage renal disease in a Swedish population.
    Thorman R; Neovius M; Hylander B
    Scand J Urol Nephrol; 2009; 43(2):154-9. PubMed ID: 18949632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood coagulation disorders in patients with chronic renal insufficiency].
    Labos I; Ajdar M; Zeljković V; Goronja M
    Med Arh; 1978; 32(1):17-21. PubMed ID: 713609
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.